Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Disorders01:29

Bone Disorders

7.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
7.9K
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

1.0K
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
1.0K
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

8.4K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
8.4K
What is the Skeletal System?01:02

What is the Skeletal System?

45.6K
Overview
45.6K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Bone Remodeling01:40

Bone Remodeling

34.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
34.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redox Network Failure in Chronic Kidney Disease: Hydrogen Sulfide Deficiency, Reactive Sulfur Species Dysregulation and the Uremic Toxin-AhR-Mitochondrial Axis.

Antioxidants (Basel, Switzerland)·2026
Same author

Reduced Serum Uric Acid and Albumin Levels in Patients with Migraine: A Cross-Sectional Study.

Journal of clinical medicine·2026
Same author

Circadian Influences on Chronic Kidney Disease Progression: Molecular Signaling Pathways of Melatonin and Their Therapeutic Potential.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

CGRP-uric acid axis in migraine: A redox-inflammatory framework linking neurovascular signaling and metabolic regulation.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Expanding Outcomes Beyond Chronic Kidney Disease-Mineral and Bone Disorder: A Propensity Score-Matched Analysis of Parathyroidectomy versus Calcimimetics in Dialysis Patients with Secondary Hyperparathyroidism.

International journal of medical sciences·2026
Same author

Effect of bariatric surgery timing on breast cancer incidence: Real-world evidence from TriNetX.

Breast (Edinburgh, Scotland)·2026

Related Experiment Video

Updated: Apr 25, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

1.8K

Vascular calcification and renal bone disorders.

Kuo-Cheng Lu1, Chia-Chao Wu2, Jen-Fen Yen3

  • 1Division of Nephrology, Department of Medicine, Cardinal Tien Hospital, School of Medicine, Fu Jen Catholic University, New Taipei City 23148, Taiwan.

Thescientificworldjournal
|August 20, 2014
PubMed
Summary
This summary is machine-generated.

Chronic kidney disease-mineral bone disorder (CKD-MBD) disrupts bone turnover and promotes vascular calcification (VC) in CKD patients. Managing bone turnover is key to preventing VC and improving patient outcomes.

More Related Videos

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

19.6K
Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models
09:01

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Published on: January 27, 2023

1.9K

Related Experiment Videos

Last Updated: Apr 25, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

1.8K
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

19.6K
Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models
09:01

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Published on: January 27, 2023

1.9K

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Biology

Background:

  • Chronic kidney disease (CKD) initiates changes in mineral metabolism and bone, termed chronic kidney disease-mineral bone disorder (CKD-MBD).
  • Bone turnover disorders and vascular calcification (VC) are common, high-mortality complications in CKD patients.
  • VC is influenced by complex factors including mineral imbalances, inflammation, and hormonal signaling.

Purpose of the Study:

  • To review the multifaceted mechanisms underlying vascular calcification in CKD-MBD.
  • To explore the interplay between bone turnover status and vascular calcification.
  • To discuss therapeutic strategies for managing CKD-MBD and preventing VC.

Main Methods:

  • Literature review of factors influencing vascular calcification in CKD.
  • Analysis of the relationship between bone turnover states (high vs. low) and VC risk.
  • Examination of regulatory pathways including calcium, phosphate, RANK/RANKL/OPG, and Wnt inhibitors.

Main Results:

  • Both high and low bone turnover states in CKD increase the risk of vascular calcification.
  • Factors like serum calcium/phosphate, inflammation, and hormonal signaling play dual roles in promoting or inhibiting VC.
  • Calcified vessels can paradoxically inhibit bone formation via FGF23 and Wnt inhibitors, leading to fragile bones.

Conclusions:

  • CKD-MBD significantly impacts bone and vascular health, with bone turnover status critically influencing vascular calcification risk.
  • Therapeutic approaches must consider individual bone turnover status to effectively manage VC and bone fragility.
  • Maintaining normal bone turnover and preventing vascular calcification are primary goals in CKD management.